Logo image of PTHL

PHETON HOLDINGS LTD-A (PTHL) Stock Fundamental Analysis

USA - NASDAQ:PTHL - KYG713991027 - Common Stock

0.851 USD
-0.08 (-8.49%)
Last: 9/12/2025, 8:09:53 PM
0.89 USD
+0.04 (+4.58%)
After Hours: 9/12/2025, 8:09:53 PM
Fundamental Rating

2

Overall PTHL gets a fundamental rating of 2 out of 10. We evaluated PTHL against 35 industry peers in the Health Care Technology industry. The financial health of PTHL is average, but there are quite some concerns on its profitability. PTHL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PTHL has reported negative net income.
PTHL had a negative operating cash flow in the past year.
PTHL Yearly Net Income VS EBIT VS OCF VS FCFPTHL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -200K -400K -600K

1.2 Ratios

PTHL has a Return On Assets (-9.83%) which is in line with its industry peers.
PTHL has a better Return On Equity (-10.68%) than 68.57% of its industry peers.
Industry RankSector Rank
ROA -9.83%
ROE -10.68%
ROIC N/A
ROA(3y)-6.25%
ROA(5y)N/A
ROE(3y)-24.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTHL Yearly ROA, ROE, ROICPTHL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

PTHL's Gross Margin of 85.05% is amongst the best of the industry. PTHL outperforms 88.57% of its industry peers.
In the last couple of years the Gross Margin of PTHL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PTHL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5YN/A
PTHL Yearly Profit, Operating, Gross MarginsPTHL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

PTHL does not have a ROIC to compare to the WACC, probably because it is not profitable.
PTHL has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PTHL has a worse debt to assets ratio.
PTHL Yearly Shares OutstandingPTHL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
PTHL Yearly Total Debt VS Total AssetsPTHL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

An Altman-Z score of 15.46 indicates that PTHL is not in any danger for bankruptcy at the moment.
PTHL has a better Altman-Z score (15.46) than 88.57% of its industry peers.
PTHL has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
PTHL has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: PTHL outperforms 57.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 15.46
ROIC/WACCN/A
WACC8.62%
PTHL Yearly LT Debt VS Equity VS FCFPTHL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

PTHL has a Current Ratio of 12.40. This indicates that PTHL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PTHL (12.40) is better than 97.14% of its industry peers.
A Quick Ratio of 12.18 indicates that PTHL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 12.18, PTHL belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.4
Quick Ratio 12.18
PTHL Yearly Current Assets VS Current LiabilitesPTHL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

PTHL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.19%.
The Revenue for PTHL has decreased by -11.79% in the past year. This is quite bad
The Revenue for PTHL have been decreasing by -13.92% on average. This is quite bad
EPS 1Y (TTM)-56.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.9%
Revenue 1Y (TTM)-11.79%
Revenue growth 3Y-13.92%
Revenue growth 5YN/A
Sales Q2Q%-1.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTHL Yearly Revenue VS EstimatesPTHL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PTHL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTHL Price Earnings VS Forward Price EarningsPTHL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTHL Per share dataPTHL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PTHL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PHETON HOLDINGS LTD-A

NASDAQ:PTHL (9/12/2025, 8:09:53 PM)

After market: 0.89 +0.04 (+4.58%)

0.851

-0.08 (-8.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins Owners40.29%
Ins Owner ChangeN/A
Market Cap12.13M
AnalystsN/A
Price TargetN/A
Short Float %7.19%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.06
P/FCF N/A
P/OCF N/A
P/B 1.96
P/tB 1.96
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.03
BVpS0.43
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.83%
ROE -10.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.05%
FCFM N/A
ROA(3y)-6.25%
ROA(5y)N/A
ROE(3y)-24.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.24%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.4
Quick Ratio 12.18
Altman-Z 15.46
F-Score4
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.79%
Revenue growth 3Y-13.92%
Revenue growth 5YN/A
Sales Q2Q%-1.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1119.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1118.55%
OCF growth 3YN/A
OCF growth 5YN/A